Skip To Content
Bradley White | Intellectual Property Litigation Lawyer

J. Bradley White

Partner, Intellectual Property

Chair: Intellectual Property Litigation


Contact Information

bwhite@osler.com

tel: 613.787.1101

Office

Ottawa

Bar Admission

Ontario, 1998

Education
  • University of Windsor, LL.B.
  • University of Waterloo, M.Sc.
  • University of Western Ontario, B.Sc.
Language(s)
English

A partner, Brad practises complex patent litigation, including pharmaceutical proceedings under PM (NOC) Regulations. Provides strategic advice on the enforcement of patent rights and coordination and management of litigation strategies throughout multiple jurisdictions. Appeared as lead counsel before the Federal Court of Appeal, Federal Court, Ontario Superior Court and as worldwide coordinating litigation and IP counsel before the US International Trade Commission. A Registered Patent Agent, he specialises in Canadian and foreign patent and industrial design prosecution, strategic IP portfolio reviews, patentability, patent infringement and validity opinions, worldwide patent portfolio management and enforcement advice. Registered to practise before the USPTO and is a past associate editor of the Canadian Patent Reporter. Rankings include: The Canadian Legal Lexpert® Directory 2019: Intellectual Property, IP Litigation, Biotechnology; Lexpert® US/Canada Cross-Border Guide — Litigation 2017; Best Lawyers in Canada 2019: (Patent and Litigation); Chambers Global 2018: IP Litigation, Intellectual Property; IAM Patent 1000 2018 and Managing IP 2018-2019: IP Star Canada; Benchmark Litigation 2018: Litigation Star; Acritas Star Lawyer and Who’s Who Legal 2019 (Life Sciences).

    Mylan Pharmaceuticals ULC :  Lead outside counsel to Mylan Pharmaceuticals ULC in patent and other matters. Successfully represented Mylan Pharmaceuticals ULC in an application commenced by Takeda Pharmaceuticals in Federal Court of Canada (T-1161-13) under the Patented Medicines (Notice of Compliance) Regulations in respect of the drug pantoprazole magnesium (TECTA®).   2015 FC 751

    Presently representing or successfully settled numerous complex pharmaceutical and general litigation matters including:

    • Novartis Pharmaceuticals v Mylan Pharmaceuticals ULC et al. T-365-14
    • Janssen Inc. v Mylan Pharmaceuticals ULC et al. T-1577-14
    • Amgen Canada Inc. v Mylan Pharmaceuticals ULC et al. T-2056-14
    • AstraZeneca Canada Inc. et al. v Mylan Pharmaceuticals ULC et al. T-336-15
    • Sanofi-Aventis v Mylan Pharmaceuticals ULC T-1441-12
    • Takeda Pharmaceuticals et al v Mylan Pharmaceuticals ULC T-1451-11
    • AstraZeneca et al v Mylan Pharmaceuticals ULC et al. 2011 FC 312, 2012 FCA 109
    • Pfizer Canada Inc et al v Mylan Pharmaceuticals ULC et al.2011 FC 547; 2012 FCA 103
    • Lundbeck Canada Inc. v Mylan Pharmaceuticals ULC et al. (2009) 73 C.P.R. (4th) 69 (F.C.T.D.); (2010) 88 C.P.R. (4th) 325 (F.C.A.), SCC 34068
    • Nycomed v. Genpharm ULC et al. 2008 FC 330, (2008), 64 C.P.R. (4th) 388 (F.C.T.D.)
    • Janssen-Ortho Inc. and Daiichi Pharmaceutical Co, Ltd.  v. Novopharm Ltd. et al. 2006 FC 1333, (2006) 57 C.P.R. (4th) 6 and 58 (F.C.T.D.)
    • Abbott Laboratories v. ratiopharm inc. et al. (2005), 45 C.P.R. (4th) 468 (F.C.T.D.)
    • Abbott Laboratories v. ratiopharm inc. et al. (2005), 42 C.P.R. (4th) 20 and 121 (F.C.T.D.)
    • Janssen-Ortho Inc. v. Novopharm Ltd. et al. (2005), 39 C.P.R. (4th) 197 (F.C.A.)
    • Janssen-Ortho Inc. v. Novopharm Ltd. et al. (2004), 35 C.P.R.(4th) 353 (F.C.T.D.), appeal dismissed (2005), 40 C.P.R. (4th) 1 (F.C.A.)
    • Abbott Laboratories v. ratiopharm inc. et al. (2004), 31 C.P.R. (4th) 321 (F.C.A.)

    Samsung Bioepis:  Representing Samsung Bioepis in first case brought under the Patented Medicines (Notice of Compliance) Regulations in relation to blockbuster biopharmaceutical ENBREL® (etanercept).

    • Amgen Canada Inc. and Immunex Corporation v. Samsung Bioepis Co., Ltd. and The Minister of Health T-1283-15

    Standard Innovation Corporation: In the role of world-wide coordinating litigation and IP counsel acted or acting for Standard Innovation Corporation, including in the following cases:

    • Appeal from the US International Trade Commission, Investigation No. 337-TA-823, United States Court of Appeals for the Federal Circuit, No. 2013-1582, Lelo Inc. & Leloi AB v. International Trade Commission and Standard Innovation (US) Corp. & Standard Innovation Corporation
    • District Court Action before the United States District Court of Northern California  5:13-cv-01393-PSG: Lelo Inc v  Standard Innovation  US Corp  and  Standard  Innovation Corporation
    • Two Inter Partes Review Re: Standard Innovation Corporation (Petitioner) v. Lelo Inc. [Patent Owner; Cases IPR2014-00148 and IPR2014-00907, Re: United States Patent No. 7,749,178 (“the ‘178 Patent”)].
    • Ex Parte reexamination of the United States Patent No. 7,931,605 (“the ‘605 Patent”)
    • Lead Canadian IP  counsel to Standard Innovation Corporation including in T-925-12: Standard Innovation Corporation  v. LELOI AB et Lelo Inc., 1531011 Ontario Inc., Cana International Distributing Inc., Landco Import International Inc. and TBMBM Inc.

Chambers

  • Chambers Canada: Canada’s Leading Lawyers for Business, 2016-2019: Intellectual Property: Litigation
  • Chambers Global: The World’s Leading Lawyers for Business, 2015 and 2017-2019: Intellectual Property Litigation and Intellectual Property
    • The "very practical" Bradley White is appreciated by clients as an adviser who "cuts to the chase quickly and tells us things straight." He is the lead partner advising Mylan Pharmaceuticals regarding its Canadian patent litigation claims, as well as a number of class action and other cases in which it is involved.
  • Chambers Canada: Canada’s Leading Lawyers for Business, 2016-2018: Intellectual Property

Lexpert

  • The Canadian Legal Lexpert Directory, 2015-2019: Intellectual Property; Biotechnology and Litigation – Intellectual Property
  • Lexpert Guide to the Leading US/Canada Cross-Border Litigation Lawyers, 2009: Canadian Litigation Lawyer to Watch

Benchmark Litigation

  • Benchmark Litigation Canada, 2015-2019: "Litigation Star", Intellectual Property

Who’s Who Legal

  • Who's Who Legal: International - Life Sciences - Patent Litigation 2019
  • Who’s Who Legal: International - Patents 2019
  • Who's Who Legal: Canada - Life Sciences 2018

Best Lawyers

  • The Best Lawyers in Canada, 2011-2019: Intellectual Property Law

Intellectual Asset Magazine

  • IAM Strategy 300: The World’s Leading IP Strategists 2019

  • Intellectual Asset Magazine (IAM) Patent 1000: World's Leading Patent Professionals, 2017-2018: One of the World’s Leading Patent Litigators and Prosecutors

  • Intellectual Asset Management  Patent 1000, 2012-2016: One of the World’s Leading Patent Practitioners
  • Intellectual Asset Magazine (IAM) 250 World’s Leading Patent Litigators, 2011: One of the World’s Leading Patent Litigators
  • International Asset Magazine (IAM) Life Science 250, 2010: One of the World’s Leading Life Sciences Litigators

Managing IP

  • Managing IP, 2014-2019, (Canada): IP Star, Patent, Copyright

Legal 500

  • The Legal 500, 2019: Leading Lawyer, Intellectual Property

Acritas Stars

  • Acritas Stars, 2018-2019: Star Lawyer

Expert Guides

  • Expert Guides: The Legal Media Group Guides to the World’s Leading Lawyers, 2013-2018: Patents Practitioners

  • Royal Ottawa Golf Club, Past Board Member (3 years service)

  • Intellectual Property Institute of Canada
  • American Intellectual Property Law Association
  • International Association for the Protection of Intellectual Property (AIPPI)
  • Canadian Bar Association

Scientific Publications

  • Co-author of the Canadian Intellectual Property Guide 2018 published by the Chinese National Intellectual Property Administration (CNIPA - formerly SIPO).
  • J.B.White, M.Dulick and P.F. Bernath, The High Resolution Infrared Emission Spectra of InH and InD, J. Mol. Spec., 169, 410-420 (1995).
  • T. Karkanis, Z. Morbi, J.B. White, M. Dulick and P.F. Bernath, The High Resolution Infrared Emission Spectrum of InF, Canadian J. Phys., 72, 1213-1217 (1994).
  • R. LeBlanc, J.B. White and P,F. Bernath, Improved Rotational Constants far HCI and HF, J, Mol, Spec., 164, 574 (1994).
  • J.B. White, M,Dulick and P.F. Bernath, The High Resolution Infrared Emission Spectra of AIH and AID J. Chem. Phys., 99, 8371 (Dec. 1993).
  • J.Campbell, M.Dulick, D.Klapstein, J.B. White and P.F.Bernath, The High Resolution Infrared Emission Spectra of GaH and GaD, J Chem. Phys., 99, 8379 (Dec. 1993).

Other Publications

  • Key issues for senior life sciences executives, IP in the Life Sciences Industries 2014 (This article first appeared in Intellectual Asset Management issue 66, published by The IP Media Group. To view the report in full, go to www.iam-magazine.com)